Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Kalil

Showing results (31-40 of 345) with videos related to

Pageof 35
Sort By:
The Journal of Allergy and Clinical Immunology|July 8, 2008
Omalizumab and Churg-Strauss syndromePedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2007
Three months' administration of anti-IgE to a patient with Churg-Strauss syndromePedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
International Archives of Allergy and Immunology|May 31, 2007
Administration of anti-IgE to a Churg-Strauss syndrome patientPedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
Immunology|August 10, 2006
TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigensIdania Marrero, Donald Huffman, Jorge Kalil, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Debate on drugs that may aggravate COVID-19Pedro Giavina-Bianchi, Marcelo Vivolo Aun, Rosana Câmara Agondi, et al.
Advances in Parasitology|September 3, 2011
AutoimmunityEdecio Cunha-Neto, Priscila Camillo Teixeira, Luciana Gabriel Nogueira, et al.
Current Opinion in Allergy and Clinical Immunology|July 1, 2016
Angioedema associated with nonsteroidal anti-inflammatory drugsPedro Giavina-Bianchi, Marcelo Vivolo Aun, Edgardo José Jares, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
Fluticasone furoate nasal spray in the treatment of allergic rhinitisPedro Giavina-Bianchi, Rosana Agondi, Rafael Stelmach, et al.
The World Allergy Organization Journal|July 21, 2025
Type 2 Inflammatory Syndrome: Atopic and non-atopic endotypesPedro Giavina-Bianchi, Rosana Camara Agondi, Marcelo Vivolo Aun, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2008
Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptomsRosana Câmara Agondi, Maria Lavínea Machado, Jorge Kalil, et al.
Pageof 35

Showing results (31-40 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Allergy and Clinical Immunology|July 8, 2008
Omalizumab and Churg-Strauss syndromePedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
The Journal of Allergy and Clinical Immunology|March 14, 2007
Three months' administration of anti-IgE to a patient with Churg-Strauss syndromePedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
International Archives of Allergy and Immunology|May 31, 2007
Administration of anti-IgE to a Churg-Strauss syndrome patientPedro Giavina-Bianchi, Mara Giavina-Bianchi, Rosana Agondi, et al.
Immunology|August 10, 2006
TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigensIdania Marrero, Donald Huffman, Jorge Kalil, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Debate on drugs that may aggravate COVID-19Pedro Giavina-Bianchi, Marcelo Vivolo Aun, Rosana Câmara Agondi, et al.
Advances in Parasitology|September 3, 2011
AutoimmunityEdecio Cunha-Neto, Priscila Camillo Teixeira, Luciana Gabriel Nogueira, et al.
Current Opinion in Allergy and Clinical Immunology|July 1, 2016
Angioedema associated with nonsteroidal anti-inflammatory drugsPedro Giavina-Bianchi, Marcelo Vivolo Aun, Edgardo José Jares, et al.
Therapeutics and Clinical Risk Management|August 30, 2008
Fluticasone furoate nasal spray in the treatment of allergic rhinitisPedro Giavina-Bianchi, Rosana Agondi, Rafael Stelmach, et al.
The World Allergy Organization Journal|July 21, 2025
Type 2 Inflammatory Syndrome: Atopic and non-atopic endotypesPedro Giavina-Bianchi, Rosana Camara Agondi, Marcelo Vivolo Aun, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2008
Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptomsRosana Câmara Agondi, Maria Lavínea Machado, Jorge Kalil, et al.
Pageof 35